PPARγ coactivator-1α (PGC-1α) protects neuroblastoma cells against amyloid-beta (Aβ) induced cell death and neuroinflammation via NF-κB pathway
Open Access
- 25 September 2017
- journal article
- research article
- Published by Springer Nature in BMC Neuroscience
- Vol. 18 (1) , 1-8
Abstract
Alzheimer’s disease is characterized by the accumulation of amyloid beta (Aβ) and the formation of neurofibrillary tangles. Aβ is the main constituent of senile plaques and is largely involved in neuronal death and neuroinflammation. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) is one of the main transcriptional coactivator and has been related to many fields such as energy metabolism, cardiovascular disease, neurodegenerative disorders, and so on. Treatment with Aβ1–42 reduced the expression of PGC-1α in both protein and RNA levels of neuroblastoma N2a cells. Aβ1–42 induced a robust activation of cleaved caspase-3 while PGC-1α suppressed this activation and protected N2a cells from Aβ-induced cell death. Overexpression of PGC-1α significantly reduced the level of main proinflammatory cytokines. In addition, PGC-1α inhibited the transportation of NF-κB p65 from cytoplasm to nucleus and IκBα degradation induced by Aβ1–42. Our results have demonstrated that PGC-1α can protect neuroblastoma cells against Aβ-induced neuronal death and neuroinflammation. Moreover, this neuroprotective effect of PGC-1α is regulated through NF-κB pathway. Taken together, our work provides evidence that PGC-1α could be beneficial in targeting Aβ neurotoxicity.Keywords
This publication has 37 references indexed in Scilit:
- Nuclear Factor-κB Regulates βAPP and β- and γ-Secretases Differently at Physiological and Supraphysiological Aβ ConcentrationsJournal of Biological Chemistry, 2012
- Developing β‐secretase inhibitors for treatment of Alzheimer’s diseaseJournal of Neurochemistry, 2011
- Activation of PERK Signaling Attenuates Aβ-Mediated ER StressPLOS ONE, 2010
- Expression and genetic analysis of tumor necrosis factor-α (TNF-α) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China populationBrain Research, 2009
- Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2007
- Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathologyJournal of Clinical Investigation, 2007
- Interleukin-1ß and Caspase-1: Players in the Regulation of Age-related Cognitive DysfunctionReviews in the Neurosciences, 2007
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Interleukin-1, neuroinflammation, and Alzheimer's diseaseNeurobiology of Aging, 2001
- Microglia and the Immune Pathology of Alzheimer DiseaseThe American Journal of Human Genetics, 1999